Activation effects of a prion protein fragment [PrP-(106-126)] on human leucocytes

Luisa Diomede, Silvano Sozzani, Walter Luini, Marina Algeri, Luca De Gioia, Roberto Chiesa, Patricia M J Lievens, Orso Bugiani, Gianluigi Forloni, Fabrizio Tagliavini, Mario Salmona

Research output: Contribution to journalArticle

Abstract

Prion-related encephalopathies are characterized by the intracerebral accumulation of an abnormal isoform of the cellular prion protein (PrP(C)) named scrapie prion protein (PrP(sc)). The pathological forms of this protein and its cellular precursor are not only expressed in the brain but also, at lower concentrations, in peripheral tissues. We recently showed that a synthetic peptide corresponding to residues 106-126 [PrP-(106-126) of the human PrP is toxic to neurons and trophic to astrocytes in vitro. Our experiments were aimed at verifying whether PrP-(106-126) and other peptides corresponding to fragments of the amyloid protein purified from brai ns of patients with Gerstmann-Straussler-Scheinker disease - namely PrP-(89-106), PrP-(106-114), PrP-(127-147)- were capable of stimulating circulating leucocytes. Native PrP expression in human lymphocytes, monocytes and neutrophils was first confirmed using PCR amplification of total RNA, after reverse transcription, and immunoblot analysis of cell extracts with anti-PrP antibodies, PrP-(106-126), but not the other peptides, increased membrane microviscosity, intracellular Ca2+ concentration and cell migration in circulating leucocytes, and O2(→) production in monocytes and neutrophils. Membrane microviscosity was determined by the fluorescence polarization technique, using diphenylhexatriene as a probe, 300 s after the addition of PrP-(106-126) to the cell suspension in the concentration range 5-50 μM. The increase in intracellular Ca2+ elicited by PrP-(106-126) was dose-dependent in the range 5-500 μM. PrP-(106-126) stimulated O2→ production in monocytes and neutrophils in a dose- (10-300 μM) and time(5-30min) dependent manner in the presence of 10 μM dihydrocytochalasin B. Both the increase in Ca2+ concentration and the 02→ production were partially sensitive to pertussis toxin. PrP-(106-126) stimulated leucocyte migration in a dose-dependent (30-300 μM) manner and, at the highest concentration used, this migration was comparable with that elicited by 2.5 nM interleukin 8 or 10 nM fMet-Leu-Phe peptide.

Original languageEnglish
Pages (from-to)563-570
Number of pages8
JournalBiochemical Journal
Volume320
Issue number2
Publication statusPublished - Dec 1 1996

Fingerprint

Leukocytes
Chemical activation
Monocytes
Peptides
Neutrophils
Gerstmann-Straussler-Scheinker Disease
Diphenylhexatriene
Membranes
N-Formylmethionine Leucyl-Phenylalanine
Amyloidogenic Proteins
Scrapie
Intracellular Membranes
Fluorescence Polarization
Lymphocytes
Prions
Poisons
Pertussis Toxin
Brain Diseases
Transcription
Protein C

ASJC Scopus subject areas

  • Biochemistry

Cite this

Activation effects of a prion protein fragment [PrP-(106-126)] on human leucocytes. / Diomede, Luisa; Sozzani, Silvano; Luini, Walter; Algeri, Marina; De Gioia, Luca; Chiesa, Roberto; Lievens, Patricia M J; Bugiani, Orso; Forloni, Gianluigi; Tagliavini, Fabrizio; Salmona, Mario.

In: Biochemical Journal, Vol. 320, No. 2, 01.12.1996, p. 563-570.

Research output: Contribution to journalArticle

@article{5e77316e2a844755bd50bcab67108a2a,
title = "Activation effects of a prion protein fragment [PrP-(106-126)] on human leucocytes",
abstract = "Prion-related encephalopathies are characterized by the intracerebral accumulation of an abnormal isoform of the cellular prion protein (PrP(C)) named scrapie prion protein (PrP(sc)). The pathological forms of this protein and its cellular precursor are not only expressed in the brain but also, at lower concentrations, in peripheral tissues. We recently showed that a synthetic peptide corresponding to residues 106-126 [PrP-(106-126) of the human PrP is toxic to neurons and trophic to astrocytes in vitro. Our experiments were aimed at verifying whether PrP-(106-126) and other peptides corresponding to fragments of the amyloid protein purified from brai ns of patients with Gerstmann-Straussler-Scheinker disease - namely PrP-(89-106), PrP-(106-114), PrP-(127-147)- were capable of stimulating circulating leucocytes. Native PrP expression in human lymphocytes, monocytes and neutrophils was first confirmed using PCR amplification of total RNA, after reverse transcription, and immunoblot analysis of cell extracts with anti-PrP antibodies, PrP-(106-126), but not the other peptides, increased membrane microviscosity, intracellular Ca2+ concentration and cell migration in circulating leucocytes, and O2(→) production in monocytes and neutrophils. Membrane microviscosity was determined by the fluorescence polarization technique, using diphenylhexatriene as a probe, 300 s after the addition of PrP-(106-126) to the cell suspension in the concentration range 5-50 μM. The increase in intracellular Ca2+ elicited by PrP-(106-126) was dose-dependent in the range 5-500 μM. PrP-(106-126) stimulated O2→ production in monocytes and neutrophils in a dose- (10-300 μM) and time(5-30min) dependent manner in the presence of 10 μM dihydrocytochalasin B. Both the increase in Ca2+ concentration and the 02→ production were partially sensitive to pertussis toxin. PrP-(106-126) stimulated leucocyte migration in a dose-dependent (30-300 μM) manner and, at the highest concentration used, this migration was comparable with that elicited by 2.5 nM interleukin 8 or 10 nM fMet-Leu-Phe peptide.",
author = "Luisa Diomede and Silvano Sozzani and Walter Luini and Marina Algeri and {De Gioia}, Luca and Roberto Chiesa and Lievens, {Patricia M J} and Orso Bugiani and Gianluigi Forloni and Fabrizio Tagliavini and Mario Salmona",
year = "1996",
month = "12",
day = "1",
language = "English",
volume = "320",
pages = "563--570",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "2",

}

TY - JOUR

T1 - Activation effects of a prion protein fragment [PrP-(106-126)] on human leucocytes

AU - Diomede, Luisa

AU - Sozzani, Silvano

AU - Luini, Walter

AU - Algeri, Marina

AU - De Gioia, Luca

AU - Chiesa, Roberto

AU - Lievens, Patricia M J

AU - Bugiani, Orso

AU - Forloni, Gianluigi

AU - Tagliavini, Fabrizio

AU - Salmona, Mario

PY - 1996/12/1

Y1 - 1996/12/1

N2 - Prion-related encephalopathies are characterized by the intracerebral accumulation of an abnormal isoform of the cellular prion protein (PrP(C)) named scrapie prion protein (PrP(sc)). The pathological forms of this protein and its cellular precursor are not only expressed in the brain but also, at lower concentrations, in peripheral tissues. We recently showed that a synthetic peptide corresponding to residues 106-126 [PrP-(106-126) of the human PrP is toxic to neurons and trophic to astrocytes in vitro. Our experiments were aimed at verifying whether PrP-(106-126) and other peptides corresponding to fragments of the amyloid protein purified from brai ns of patients with Gerstmann-Straussler-Scheinker disease - namely PrP-(89-106), PrP-(106-114), PrP-(127-147)- were capable of stimulating circulating leucocytes. Native PrP expression in human lymphocytes, monocytes and neutrophils was first confirmed using PCR amplification of total RNA, after reverse transcription, and immunoblot analysis of cell extracts with anti-PrP antibodies, PrP-(106-126), but not the other peptides, increased membrane microviscosity, intracellular Ca2+ concentration and cell migration in circulating leucocytes, and O2(→) production in monocytes and neutrophils. Membrane microviscosity was determined by the fluorescence polarization technique, using diphenylhexatriene as a probe, 300 s after the addition of PrP-(106-126) to the cell suspension in the concentration range 5-50 μM. The increase in intracellular Ca2+ elicited by PrP-(106-126) was dose-dependent in the range 5-500 μM. PrP-(106-126) stimulated O2→ production in monocytes and neutrophils in a dose- (10-300 μM) and time(5-30min) dependent manner in the presence of 10 μM dihydrocytochalasin B. Both the increase in Ca2+ concentration and the 02→ production were partially sensitive to pertussis toxin. PrP-(106-126) stimulated leucocyte migration in a dose-dependent (30-300 μM) manner and, at the highest concentration used, this migration was comparable with that elicited by 2.5 nM interleukin 8 or 10 nM fMet-Leu-Phe peptide.

AB - Prion-related encephalopathies are characterized by the intracerebral accumulation of an abnormal isoform of the cellular prion protein (PrP(C)) named scrapie prion protein (PrP(sc)). The pathological forms of this protein and its cellular precursor are not only expressed in the brain but also, at lower concentrations, in peripheral tissues. We recently showed that a synthetic peptide corresponding to residues 106-126 [PrP-(106-126) of the human PrP is toxic to neurons and trophic to astrocytes in vitro. Our experiments were aimed at verifying whether PrP-(106-126) and other peptides corresponding to fragments of the amyloid protein purified from brai ns of patients with Gerstmann-Straussler-Scheinker disease - namely PrP-(89-106), PrP-(106-114), PrP-(127-147)- were capable of stimulating circulating leucocytes. Native PrP expression in human lymphocytes, monocytes and neutrophils was first confirmed using PCR amplification of total RNA, after reverse transcription, and immunoblot analysis of cell extracts with anti-PrP antibodies, PrP-(106-126), but not the other peptides, increased membrane microviscosity, intracellular Ca2+ concentration and cell migration in circulating leucocytes, and O2(→) production in monocytes and neutrophils. Membrane microviscosity was determined by the fluorescence polarization technique, using diphenylhexatriene as a probe, 300 s after the addition of PrP-(106-126) to the cell suspension in the concentration range 5-50 μM. The increase in intracellular Ca2+ elicited by PrP-(106-126) was dose-dependent in the range 5-500 μM. PrP-(106-126) stimulated O2→ production in monocytes and neutrophils in a dose- (10-300 μM) and time(5-30min) dependent manner in the presence of 10 μM dihydrocytochalasin B. Both the increase in Ca2+ concentration and the 02→ production were partially sensitive to pertussis toxin. PrP-(106-126) stimulated leucocyte migration in a dose-dependent (30-300 μM) manner and, at the highest concentration used, this migration was comparable with that elicited by 2.5 nM interleukin 8 or 10 nM fMet-Leu-Phe peptide.

UR - http://www.scopus.com/inward/record.url?scp=0029910449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029910449&partnerID=8YFLogxK

M3 - Article

C2 - 8973567

AN - SCOPUS:0029910449

VL - 320

SP - 563

EP - 570

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 2

ER -